preprints.org > medicine and pharmacology > gastroenterology and hepatology > doi: 10.3390/sci2010003

Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Version 1 : Received: 13 December 2019 / Approved: 10 January 2020 / Online: 13 January 2020 (00:00:00 CET)
Version 2 : Received: 13 December 2019 / Approved: 10 January 2020 / Online: 10 June 2020 (00:00:00 CEST)

The clinical characterization of small hepatocellular carcinoma (HCC) lesions in the liver and differentiation from heterogeneous inflammatory or fibrotic background is important for early detection and treatment. Metabolic monitoring of hyperpolarized ¹³C-labeled substrates has been suggested as a new avenue for diagnostic magnetic resonance. The metabolism of hyperpolarized [1-¹³C]pyruvate was monitored in mouse precision-cut liver slices (PCLS) of aged MDR2-KO mice, which served as a model for heterogeneous liver and HCC that develops similarly to the human disease. The relative in-cell activities of lactate dehydrogenase (LDH) to alanine transaminase (ALT) were found to be 0.40 ± 0.06 (n = 3) in healthy livers (from healthy mice), 0.90 ± 0.27 (n = 3) in heterogeneously inflamed liver, and 1.84 ± 0.46 (n = 3) in HCC. Thus, the in-cell LDH/ALT activities ratio was found to correlate with the progression of the disease. The results suggest that the LDH/ALT activities ratio may be useful in the assessment of liver disease. Because the technology used here is translational to both small liver samples that may be obtained from image-guided biopsy (i.e., ex vivo investigation) and to the intact liver (i.e., in a non-invasive MRI scan), these results may provide a path for differentiating heterogeneous liver from HCC in human subjects.

lactate dehydrogenase; alanine transaminase; MDR2 knockout; dissolution dynamic nuclear polarization; perfused precision cut liver slices

Medicine and Pharmacology, Gastroenterology and Hepatology

* All users must log in before leaving a comment